Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 23, 2019
Reply
Martinus A Cozijnsen, Dan Turner
The Cochrane Database of Systematic Reviews
|
February 23, 2017
Prophylactic drug management for febrile seizures in children
Martin Offringa, Richard Newton, Martinus A Cozijnsen, et al.
Inflammatory Bowel Diseases
|
February 28, 2015
Benefits and risks of combining anti-tumor necrosis factor with immunomodulator therapy in pediatric inflammatory bowel disease
Martinus A Cozijnsen, Johanna C Escher, Anne Griffiths, et al.
International Journal of Cardiology
|
October 12, 2016
Knowledge of native valve anatomy is essential in follow-up of patients after aortic valve replacement
Luc Cozijnsen, Hester J van der Zaag-Loonen, Martinus A Cozijnsen, et al.
Journal of Crohn'S & Colitis
|
March 19, 2023
Serum Immune Profiling in Paediatric Crohn's Disease Demonstrates Stronger Immune Modulation With First-Line Infliximab Than Conventional Therapy and Pre-Treatment Profiles Predict Clinical Response to Both Treatments
Maria M E Jongsma, Lea M M Costes, Irma Tindemans, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 14, 2019
Development and Validation of the Mucosal Inflammation Noninvasive Index For Pediatric Crohn's Disease
Martinus A Cozijnsen, Assaf Ben Shoham, Ben Kang, et al.
European Journal of Pediatrics
|
June 7, 2022
Evaluation of exclusive enteral nutrition and corticosteroid induction treatment in new-onset moderate-to-severe luminal paediatric Crohn's disease
Maria M E Jongsma, Stephanie A Vuijk, Martinus A Cozijnsen, et al.
Gut
|
January 1, 2021
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial
Maria M E Jongsma, Martine A Aardoom, Martinus A Cozijnsen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 23, 2019
Reply
Martinus A Cozijnsen, Dan Turner
The Cochrane Database of Systematic Reviews
|
February 23, 2017
Prophylactic drug management for febrile seizures in children
Martin Offringa, Richard Newton, Martinus A Cozijnsen, et al.
Inflammatory Bowel Diseases
|
February 28, 2015
Benefits and risks of combining anti-tumor necrosis factor with immunomodulator therapy in pediatric inflammatory bowel disease
Martinus A Cozijnsen, Johanna C Escher, Anne Griffiths, et al.
International Journal of Cardiology
|
October 12, 2016
Knowledge of native valve anatomy is essential in follow-up of patients after aortic valve replacement
Luc Cozijnsen, Hester J van der Zaag-Loonen, Martinus A Cozijnsen, et al.
Journal of Crohn'S & Colitis
|
March 19, 2023
Serum Immune Profiling in Paediatric Crohn's Disease Demonstrates Stronger Immune Modulation With First-Line Infliximab Than Conventional Therapy and Pre-Treatment Profiles Predict Clinical Response to Both Treatments
Maria M E Jongsma, Lea M M Costes, Irma Tindemans, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 14, 2019
Development and Validation of the Mucosal Inflammation Noninvasive Index For Pediatric Crohn's Disease
Martinus A Cozijnsen, Assaf Ben Shoham, Ben Kang, et al.
European Journal of Pediatrics
|
June 7, 2022
Evaluation of exclusive enteral nutrition and corticosteroid induction treatment in new-onset moderate-to-severe luminal paediatric Crohn's disease
Maria M E Jongsma, Stephanie A Vuijk, Martinus A Cozijnsen, et al.
Gut
|
January 1, 2021
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial
Maria M E Jongsma, Martine A Aardoom, Martinus A Cozijnsen, et al.
Page
of 1